Drupal.behaviors.print = function(context) {window.print();window.close();}>
US, European Funding Woes Hurt Illumina's Q3 Sales; Effect on Arrays Unclear
October 11, 2011
US, European Funding Woes Hurt Illumina's Q3 Sales; Effect on Arrays Unclear
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Illumina CEO Discusses ENCODE, GWAS, and NIH Funding at Investor Conference
September 18, 2012 / BioArray News
Illumina Opens Office in Brazil to Target 'Increasing' Latin American Market
January 25, 2011 / BioArray News
Illumina Q3 Sales Rise 50 Percent on 'Substantial' Demand for Arrays, Sequencers
November 2, 2010 / BioArray News
Illumina's Q2 Array Revenues Rise on Whole-Genome Omni BeadChip Sales
August 3, 2010 / BioArray News
Aiming at '$12B Opportunity,' Illumina to Expand Sales Presence, Invest in Reproductive Health
May 14, 2013 / BioArray News